| Clinical applications of thrombolytic therapy. | |
| | |
MedLine Citation:
|
PMID: 8900363 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Although thrombolytic therapy is used in a variety of settings, it has gained the most prominence in the treatment of myocardial infarction. The effectiveness of thrombolytic agents in reducing mortality in patients who present with myocardial infarction has been clearly demonstrated by large-scale studies. Unfortunately, only a minority of patients who present with myocardial infarction are currently receiving thrombolytic therapy. Many patients who could benefit from thrombolysis are unnecessarily excluded from treatment. It is now recommended that all patients who have appropriate electrocardiographic changes and present within 12 hours of the onset of acute myocardial infarction be considered for thrombolytic therapy. Factors such as age and history of previous myocardial infarction are no longer viewed as barriers to treatment. |
| | |
Authors:
|
F S Mair |
Related Documents
:
|
9777133 - Refining the risk-benefit equation for thrombolysis: how to identify the low risk patie... 8804773 - Immediate hemodynamic effects of thrombolytic therapy on the ischemic myocardium. 3181173 - Non-invasive preoperative assessment of chronic valvular heart disease by doppler ultra... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: American family physician Volume: 54 ISSN: 0002-838X ISO Abbreviation: Am Fam Physician Publication Date: 1996 Nov |
Date Detail:
|
Created Date: 1996-12-04 Completed Date: 1996-12-04 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 1272646 Medline TA: Am Fam Physician Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 2041-8 Citation Subset: AIM; IM |
Affiliation:
|
University of Kansas Medical Center, Kansas City, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Brain Ischemia
/
drug therapy Fibrinolytic Agents / therapeutic use Humans Myocardial Infarction / drug therapy* Patient Selection Pulmonary Embolism / drug therapy Streptokinase / therapeutic use Thrombolytic Therapy* / contraindications |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; EC 3.4.-/Streptokinase |
| Comments/Corrections | |
Comment In:
|
Am Fam Physician. 1997 Sep 1;56(3):738, 741
[PMID:
9301568
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The role of diagnostic imaging in women with breast implants.
Next Document: Alendronate: a bisphosphonate for treatment of osteoporosis.